RE: Today ?30 Jun 2021 06:43
s120896, see xviolet's post, the 5 were chosen by the EU yesterday.
"Jun 29 (Reuters) – The European Commission on Tuesday chose four antibody treatments and a rheumatoid arthritis drug re-targeted by Eli Lilly for an initial portfolio of preferred drugs to treat COVID-19 disease.
The drug selection is part of the EU Strategy on COVID-19 Therapeutics, launched in May, to accelerate EU approval and for a joint procurement plan on behalf of Member States, complementing more advanced efforts in vaccines matter.
The Commission’s selection of most promising treatments includes Eli Lilly and Incyte’s Olumiant for hospitalized COVID-19 patients receiving oxygen, as well as new antibody drugs for early-stage disease developed by Regeneron, Eli Lilly, Celltrion and an alliance of GlaxoSmithKline and its partner Vir."